This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (56)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Alzheimer Disease  • Cerebrovascular Disease  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Eva Hogervorst, PhD; Helen Mendes Ribeiro, FRCR; Andrew Molyneux, FRCR; Marc Budge, FRACP; A. David Smith, DPhil

Arch Neurol. 2002;59:787-793.

Context  The pathogenesis of leukoaraiosis on computed tomographic (CT) scanning is unknown, but cerebrovascular risk factors for leukoaraiosis show overlap with those for Alzheimer disease (AD).

Objective  To investigate the contribution of cerebrovascular risk factors, in particular plasma total homocysteine (tHcy), to leukoaraiosis in patients with AD and controls.

Design  Cross-sectional case-control study.

Setting  Referral population to a hospital clinic and community volunteers from the Oxfordshire region in England seen between July 1, 1988, and July 1, 2000.

Participants  One hundred thirty-seven AD cases (104 confirmed post mortem) and 277 controls matched for age (mean ± SD, 73 ± 8 years) and sex.

Main Outcome Measures  Cerebrovascular risk factors and leukoaraiosis on CT scans of cases and controls; the odds ratio (OR) of having moderate to severe leukoaraiosis with higher levels of plasma tHcy and cerebrovascular risk factors such as age, sex, systolic blood pressure, smoking, diabetes mellitus, and apolipoprotein E 4 genotype.

Results  Leukoaraiosis was more prevalent in AD cases. For a 5-µmol/L increase in tHcy levels, the OR for leukoaraiosis was 1.40 (95% confidence interval, 1.02-1.91) independent of other risk factors. The distribution pattern of leukoaraiosis was more marked in the deep white matter than in the periventricular area in individuals with elevated tHcy levels, particularly in patients with AD.

Conclusions  Higher tHcy levels are an independent risk factor for moderate to severe leukoaraiosis in individuals with AD and of leukoaraiosis of the deep white matter in particular. The nature of the relationship between tHcy levels and leukoaraiosis in AD requires further longitudinal and intervention studies.

From the Oxford Project to Investigate Memory and Ageing, Department of Pharmacology, University of Oxford and Radcliffe Infirmary (Drs Hogervorst, Budge, and Smith); the Department of Radiology, John Radcliffe Hospital (Dr Ribeiro); and the Department of Neuroradiology, Radcliffe Infirmary (Dr Molyneux), Oxford, England.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(5):878-880.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association of Plasma Total Homocysteine Levels With Subclinical Brain Injury: Cerebral Volumes, White Matter Hyperintensity, and Silent Brain Infarcts at Volumetric Magnetic Resonance Imaging in the Framingham Offspring Study
Seshadri et al.
Arch Neurol 2008;65:642-649.
ABSTRACT | FULL TEXT  

Differential Dietary Nutrient Intake according to Hormone Replacement Therapy Use: An Underestimated Confounding Factor in Epidemiologic Studies?
Vercambre et al.
Am J Epidemiol 2007;166:1451-1460.
ABSTRACT | FULL TEXT  

Brain Imaging in Patients With Diabetes: A systematic review.
van Harten et al.
Diabetes Care 2006;29:2539-2548.
FULL TEXT  

Plasma {beta}-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
Gurol et al.
Neurology 2006;66:23-29.
ABSTRACT | FULL TEXT  

High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study
Tucker et al.
Am. J. Clin. Nutr. 2005;82:627-635.
ABSTRACT | FULL TEXT  

Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment
Boxer et al.
Neurology 2005;64:1431-1434.
ABSTRACT | FULL TEXT  

Homocysteine and cognitive function in elderly people
Garcia and Zanibbi
CMAJ 2004;171:897-904.
ABSTRACT | FULL TEXT  

Homocysteine and the Brain in Midadult Life: Evidence for an Increased Risk of Leukoaraiosis in Men
Sachdev et al.
Arch Neurol 2004;61:1369-1376.
ABSTRACT | FULL TEXT  

Total homocysteine and cognition in a tri-ethnic cohort: The Northern Manhattan Study
Wright et al.
Neurology 2004;63:254-260.
ABSTRACT | FULL TEXT  

Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia
Quadri et al.
Am. J. Clin. Nutr. 2004;80:114-122.
ABSTRACT | FULL TEXT  

Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion
Refsum et al.
Clin. Chem. 2004;50:3-32.
ABSTRACT | FULL TEXT  

"Silent" Strokes and Dementia
Blass and Ratan
NEJM 2003;348:1277-1278.
FULL TEXT